Church & Dwight (NYSE:CHD) Reaches New 1-Year Low on Analyst Downgrade

Church & Dwight Co., Inc. (NYSE:CHD)’s stock price reached a new 52-week low on Thursday after Wells Fargo & Company lowered their price target on the stock from $108.00 to $100.00. Wells Fargo & Company currently has an overweight rating on the stock. Church & Dwight traded as low as $85.61 and last traded at $85.73, with a volume of 490837 shares changing hands. The stock had previously closed at $86.86.

CHD has been the topic of a number of other research reports. Evercore ISI reduced their target price on Church & Dwight from $102.00 to $101.00 and set an “in-line” rating on the stock in a research note on Monday, August 4th. Redburn Atlantic lowered Church & Dwight from a “hold” rating to a “strong sell” rating in a research note on Monday, July 14th. Barclays dropped their price target on Church & Dwight from $84.00 to $83.00 and set an “underweight” rating on the stock in a research report on Monday, August 4th. UBS Group increased their price target on Church & Dwight from $102.00 to $103.00 and gave the stock a “neutral” rating in a research report on Thursday, July 17th. Finally, Royal Bank Of Canada raised Church & Dwight from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $100.00 to $114.00 in a research report on Monday, June 2nd. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat.com, Church & Dwight has a consensus rating of “Hold” and an average target price of $103.44.

Insider Activity at Church & Dwight

In related news, CEO Richard A. Dierker acquired 5,470 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The shares were bought at an average price of $91.57 per share, with a total value of $500,887.90. Following the completion of the transaction, the chief executive officer directly owned 27,212 shares in the company, valued at $2,491,802.84. This trade represents a 25.16% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael Read acquired 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 5th. The shares were bought at an average cost of $91.27 per share, for a total transaction of $182,540.00. Following the transaction, the executive vice president owned 7,505 shares of the company’s stock, valued at $684,981.35. This represents a 36.33% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 12,879 shares of company stock valued at $1,177,702 over the last quarter. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Church & Dwight

A number of institutional investors have recently added to or reduced their stakes in CHD. IAG Wealth Partners LLC boosted its position in Church & Dwight by 92.9% during the first quarter. IAG Wealth Partners LLC now owns 270 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Wayfinding Financial LLC bought a new stake in Church & Dwight during the first quarter valued at about $40,000. Versant Capital Management Inc boosted its position in Church & Dwight by 42.1% during the first quarter. Versant Capital Management Inc now owns 378 shares of the company’s stock valued at $42,000 after purchasing an additional 112 shares in the last quarter. Opal Wealth Advisors LLC acquired a new stake in Church & Dwight in the second quarter worth about $45,000. Finally, Chilton Capital Management LLC boosted its holdings in Church & Dwight by 90.9% in the first quarter. Chilton Capital Management LLC now owns 420 shares of the company’s stock worth $46,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 86.60% of the company’s stock.

Church & Dwight Stock Performance

The company has a debt-to-equity ratio of 0.50, a current ratio of 1.84 and a quick ratio of 1.33. The firm has a market cap of $20.93 billion, a price-to-earnings ratio of 40.52, a P/E/G ratio of 3.59 and a beta of 0.44. The firm has a fifty day simple moving average of $93.20 and a two-hundred day simple moving average of $97.73.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.94 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.09. The business had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.48 billion. Church & Dwight had a return on equity of 19.27% and a net margin of 8.66%.The company’s quarterly revenue was down .3% on a year-over-year basis. During the same quarter last year, the company earned $0.93 earnings per share. Church & Dwight has set its FY 2025 guidance at 3.440-3.510 EPS. Q3 2025 guidance at 0.720-0.720 EPS. On average, analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Friday, August 15th were issued a $0.295 dividend. This represents a $1.18 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Friday, August 15th. Church & Dwight’s dividend payout ratio (DPR) is currently 55.66%.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.